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Background: Recent studies have shown that some pseudogenes are transcribed and contribute to cancer when
dysregulated. In particular, pseudogene transcripts can function as competing endogenous RNAs (ceRNAs). The
high similarity of gene and pseudogene nucleotide sequence has hindered experimental investigation of these
mechanisms using RNA-seq. Furthermore, previous studies of pseudogenes in breast cancer have not integrated
miRNA expression data in order to perform large-scale analysis of ceRNA potential. Thus, knowledge of both
pseudogene ceRNA function and the role of pseudogene expression in cancer are restricted to isolated examples.
Results: To investigate whether transcribed pseudogenes play a pervasive regulatory role in cancer, we developed
a novel bioinformatic method for measuring pseudogene transcription from RNA-seq data. We applied this method
to 819 breast cancer samples from The Cancer Genome Atlas (TCGA) project. We then clustered the samples using
pseudogene expression levels and integrated sample-paired pseudogene, gene and miRNA expression data with
miRNA target prediction to determine whether more pseudogenes have ceRNA potential than expected by chance.
Conclusions: Our analysis identifies with high confidence a set of 440 pseudogenes that are transcribed in breast
cancer tissue. Of this set, 309 pseudogenes exhibit significant differential expression among breast cancer subtypes.
Hierarchical clustering using only pseudogene expression levels accurately separates tumor samples from normal
samples and discriminates the Basal subtype from the Luminal and Her2 subtypes. Correlation analysis shows more
positively correlated pseudogene-parent gene pairs and negatively correlated pseudogene-miRNA pairs than
expected by chance. Furthermore, 177 transcribed pseudogenes possess binding sites for co-expressed miRNAs
that are also predicted to target their parent genes. Taken together, these results increase the catalog of putative
pseudogene ceRNAs and suggest that pseudogene transcription in breast cancer may play a larger role than previously
appreciated.Background
Pseudogenes are genomic sequences sharing consider-
able sequence identity with protein-coding genes yet
possessing features such as premature stop codons, dele-
tions/insertions, or frameshift mutations that prevent
them from producing functional proteins. There are
three classes of pseudogenes: processed, duplicated, and
unitary. A processed pseudogene lacks introns, resem-
bling a spliced transcript that was inserted into the gen-
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unless otherwise stated.complete copy of a protein-coding gene, including in-
trons and sometimes even upstream regulatory elements.
Thus, for any processed or duplicated pseudogene, there
is an associated protein-coding gene called its parent
gene that is highly similar in sequence. The third type of
pseudogene is the unitary pseudogene, which arises
when a protein-coding gene loses its coding potential
through the accumulation of mutations. Unitary pseudo-
genes therefore do not have parent genes.
According to the GENCODE pseudogene annotations
(v.17), there are nearly 15,000 human pseudogenes.
Since their discovery in 1977, pseudogenes have gen-
erally been considered “biologically inconsequential”
and non-functional [1]. Therefore, the discovery that aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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scribed was somewhat surprising. The ENCODE project
recently performed a survey of publicly available expres-
sion data to identify transcribed pseudogenes, and found
over 800 pseudogenes with strong evidence of transcrip-
tion [3]. These transcribed pseudogenes showed both tissue-
specific and constitutive expression profiles. In addition,
many of the pseudogenes not found to be transcribed by EN-
CODE possessed properties indicative of transcription poten-
tial, including open chromatin, histone modifications that
indicate transcriptional activity, transcription factor binding,
and RNA polymerase II occupancy. Another recent study
found evidence for over 2000 expressed pseudogenes in 13
different cancer and normal tissue types [4].
Although some pseudogenes are transcribed, this fact
does not necessarily imply that pseudogene transcripts
perform biologically important functions. However, re-
cent research has revealed several mechanisms by which
pseudogenes regulate gene expression. For example, in
snail neurons, translation of the neural nitric oxide syn-
thase mRNA is blocked by an antisense pseudogene
transcript that binds to the mRNA [5]. Pseudogenes in
mouse can form double-stranded RNA by base-pairing
with their corresponding protein-coding genes and gen-
erate siRNAs to silence the expression of these genes
[6]. Pseudogenes may also compete with mRNAs for
transcript stability factors, as in the case of the human
HMGA1-p pseudogene [7].
The most recent function identified for pseudogenes is
post-transcriptional regulation of mRNA levels by com-
peting for miRNAs. This mechanism was first discovered
in animals when it was shown that two human pseudo-
genes, PTENP1 and KRASP1, are transcribed and harbor
miRNA response elements (MREs) for some of the same
miRNAs that target their corresponding protein-coding
genes, PTEN and KRAS, respectively [8]. By binding and
sequestering miRNAs that would otherwise bind and
regulate PTEN or KRAS, the corresponding pseudogenes
free the protein-coding genes from miRNA target re-
pression. Thus, if the pseudogene is transcribed at a low
level, more miRNAs will be able to target the parent
gene transcripts, whereas an increase in pseudogene
transcription will cause fewer miRNAs to target the par-
ent gene. In this way, pseudogene RNA can compete
with the parent gene RNA for miRNAs and thereby in-
fluence gene expression. This mechanism of regulation
was first characterized in plants, where it was termed
“target mimicry” [9]. Competition for miRNAs had also
been used to create exogenous “miRNA sponges” con-
taining specific MREs designed to soak up micro-
ribonucleoprotein complexes and de-repress natural
miRNA targets [10]. Salmena et al. coined the term com-
peting endogenous RNA (ceRNA) to describe the function
of PTENP1 and KRASP1 [11]. In theory, any type ofRNA molecule, including mRNA, transcribed pseudo-
genes, and long non-coding RNA (lncRNA), can func-
tion as a ceRNA, provided the molecule shares at least
one MRE with another RNA [12]. A number of ceRNAs
have been identified since the initial discovery of
PTENP1 and KRASP1, including mRNAs [13-15], and
lncRNAs [16]. Non-coding transcripts may serve as
more effective ceRNAs than mRNAs, since they are sub-
strates for miRNA binding but are not translated. The
absence of bound ribosomes on a non-coding transcript
allows miRNAs to bind freely along the entire transcript
rather than primarily in the regions that are outside the
ribosome footprint as on mRNAs [17]. Transcribed
pseudogenes are especially strong ceRNA candidates be-
cause pseudogenes are identified by alignment with
protein-coding genes, so by definition, they possess
strong sequence similarity with their corresponding par-
ent genes. This suggests that pseudogenes are likely to
share MREs with their parent protein-coding genes. In
fact, the sequence similarity between the PTEN coding
gene and the PTENP1 pseudogene was one of the initial
observations that led to the discovery of the ceRNA
function of the PTENP1 pseudogene [8].
Interestingly, several transcribed pseudogenes play a
key role in the development of cancer. PTENP1, KRASP1,
and OCT4-pg4 are known to promote tumor progression
through their roles as ceRNAs [8,18]. The pseudogenes
SUMO1P3 [19], ATP8A2-Ψ [4], and Nanog-p8 [20] have
each been shown to enable cancer progression, but the
mechanisms by which they do this are unknown. Ψ-PPM1K
was shown to suppress oncogenic cell growth in hepatocel-
lular carcinoma by generating endogenous siRNAs [21].
ATP8A2-Ψ is an especially interesting case, because it is the
first published example of a pseudogene that is differentially
expressed among cancer subtypes, showing high expression
in breast cancer samples with luminal histology but very lit-
tle expression in basal samples [4]. Also, ATP8A2-Ψ was
shown to induce tumor progression when overexpressed in
breast cancer cell lines [4].
Recently, a survey of RNA-seq data from The Cancer
Genome Atlas project spanning seven cancer types
showed that pseudogenes can be used to classify cancer
samples into clinically relevant subtypes [22]. In particu-
lar, this study found that pseudogene expression alone
separates endometrial cancer samples into groups corre-
sponding to the major histological subtypes. Another in-
teresting result from this study is that pseudogene-
defined subtypes in kidney cancer show different patient
survival rates. In addition, 547 pseudogenes with subtype-
specific expression in breast cancer were identified. Fi-
nally, using miRNA expression data in conjunction with
gene and pseudogene expression levels, they identified 38
pseudogenes with potential to function as ceRNAs in kid-
ney cancer.
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in ceRNA interactions or play a role in cancer certainly
represent provocative examples. However, the difficulty
of reliably quantifying pseudogene expression and the
lack of suitable datasets have hindered attempts to study
these phenomena on a large scale. Therefore, it is not
known whether pseudogenes like PTENP1 and ATP8A2-
Ψ represent a few anomalous cases or point to a perva-
sive regulatory mechanism.
To begin to address this open and important question,
we performed an investigation of the expression, subtype
specificity, and ceRNA potential of transcribed pseudo-
genes in breast cancer using data from The Cancer Gen-
ome Atlas project (TCGA). The data include RNA-seq
results for a total of 819 tumor and adjacent normal
samples, along with sample-paired small RNA-seq. The
dataset contains a representative sampling of breast can-
cer subtype, including 123 samples from the basal sub-
type, 60 her2 samples, 371 luminal A samples, and 170
luminal B samples. To the best of our knowledge, this
study is the first to make use of sample-paired pseudo-
gene and miRNA expression data to investigate the
ceRNA mechanism in breast cancer.
Results
Reliable quantification of pseudogene expression
Reliable quantification of pseudogene expression re-
mains a challenging problem for a number of reasons.
First, since parent genes and pseudogenes are highly
similar in nucleotide sequence, short RNA-seq reads de-
rived from one may align equally well to the other one.
Such reads are fundamentally ambiguous in terms of
their origin. Second, some reads may have nearly identi-
cal alignment to locations in the gene and pseudogene,
and their mapping is often determined by the location
with the least error in alignment. However, this strategy
is unreliable in the presence of subject-specific variation
with respect to the reference genome, or in the event of
base call errors during sequencing, since these can result
in an incorrect assignment of the read. Third, some
aligners may follow a parsimony strategy in which a
“simple” alignment is preferred to a complex (e.g.
spliced) alignment. In the case of a processed pseudo-
gene that lacks splices, this approach may erroneously
bias the alignments to the pseudogene rather than the
parent gene. Finally, in some cases, aligners report only
a subset of possible alignments as a result of the heuris-
tics used. For all of these reasons, studies of gene and
pseudogene expression using existing tools are likely in-
accurate without additional considerations.
A first approach to reliably studying pseudogene ex-
pression is to consider only the reads that are assigned
to a single location by an aligner. However, the above
confounding factors can result in reads that are uniquelyaligned to the wrong positions (Figure 1A). Any conclu-
sions drawn from such reads in downstream analyses
will be unreliable. One approach to addressing this prob-
lem is to identify and discard from the analysis reads
that map to regions in the genome that are especially
sensitive to these confounding factors. We have adopted
this approach using the concept of transcriptome mapp-
ability, which we describe below.
Our approach for computing transcriptome mappabil-
ity builds on the notion of genomic mappability. Mapp-
ability is a measure of the inherent distinctiveness of a
genomic region; the more frequently a genomic region
occurs, the less mappable it is. Although mappability
can be defined as a continuous quantity (the reciprocal
of k-mer frequencies, for example, as in [23]), it is gener-
ally not very useful to know the degree to which a region
is unmappable. If a k-mer occurs more than once in the
genome, a read aligned there will be ambiguous. For this
reason, we compute mappability as a discrete quantity –
that is, a region is either mappable (unambiguous) or
not mappable (ambiguous). Our notion of mappability
also includes a “safety margin”, so that a mappable re-
gion guarantees not only a unique alignment for the
reads matching the sequence, but also that no read with
one or two base call errors or SNPs relative to the refer-
ence genome could be uniquely mismapped to this re-
gion. Mappability is important even if an aligner does
not use heuristics and exhaustively enumerates read
alignments. As demonstrated by Figure 1A, highly simi-
lar regions can produce uniquely mismapped reads as a
result of genome variation and read errors in a way that
no aligner can recognize (see Methods section for
details).
If we restrict our attention to alignments in mappable
regions, we ensure that the downstream analysis results
are robust, even if the reference genome does not match
the subject genome or the reads contain sequencing er-
rors. Mappability is thus inversely related with sensitivity
to genome variation and read errors.
Since RNA-seq reads may span multiple exons, the
transcriptome contains additional k-mers beyond those
found in the genome. To compute transcriptome mapp-
ability, we can align k-mers to the genome sequences
crossing splice junctions. This transcriptome mappability
scheme allows the computation of pseudogene expres-
sion levels using only reads uniquely aligned to map-
pable regions. Using these reliable reads, we compute
pseudogene expression levels in units of Reads per Kilo-
base of Uniquely mappable transcript per Million reads
(RPKUM). See the Methods section for a detailed de-
scription of the transcriptome mappability and RPKUM
calculations.
We tested our RPKUM metric by comparing expres-
sion levels for protein coding genes computed with both
Figure 1 Reliable quantification of pseudogene expression. (A) Example showing that even an ideal aligner may produce uniquely
misaligned reads in the presence of mutations and read errors if alignments to unmappable regions are considered trustworthy. In this example,
the gene and pseudogene differ in one nucleotide so the regions are not identical. Now the gene in the subject genome being sequenced has
undergone mutation so it differs from the reference genome in 3 positions. RNA-seq produces reads from this gene reflecting the mutations in
the subject genome. If the reads are then mapped back to the genome allowing 2 mismatches, they map only to a pseudogene of the gene that
produced the reads. The problem arises because the sequences of the gene and pseudogene are sufficiently similar that unique misalignment
cannot be ruled out. (B) If a read has at least two alignments that are at distance δ1 and δ2 from the reference genome, respectively, then the
true position of the read should be considered ambiguous unless |δ1-δ2| > ε for some integer safety margin ε > 0. (C) Pipeline for computing
RPKUM expression levels for pseudogenes. (D) “Synthetic regions” around splice junctions are used to extend mappability to the transcriptome. A
synthetic region is constructed by concatenating k–1 nucleotides from the donor and acceptor exons on either side of a splice junction. Any k-mer that
crosses the splice junction thus occurs in the synthetic region.
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quantification method. We computed the mean expres-
sion level across the TCGA dataset for each protein-
coding gene using both methods, then calculated the
correlation between the expression levels from the two
methods. The result showed good agreement between
RPKUM and RSEM values (Spearman correlation > 0.85),
indicating that RPKUM values provide a reliable method
for quantifying expression levels.
An important question is whether RPKUM values
computed from few mappable bases are trustworthy. To
investigate the robustness of the RPKUM metric, we
simulated RPKUM values by randomly sampling posi-
tions of genes that are completely mappable and then
using these sampled bases as the only mappable bases of
a gene in an RPKUM calculation. Genes spanning a wide
range of expression levels from 1 to 200 RPKMs were
used in the simulation. We performed the simulationsAligned to Pseudogenes
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Figure 2 Pseudogene mappability and read alignments. (A) Violin plot
percentage of gene length. The dot in the middle of each plot represents
showing how many reads are removed by mappability filtering. From left t
of reads aligned to pseudogenes that are uniquely aligned; and fraction ofwith 500, 100, and 50 mappable bases per gene. RPKUM
values computed from genes with as few as 50 simulated
mappable bases showed very strong agreement with the
true RPKM expression levels across the range of expres-
sion levels (ρ = 0.95). In addition, increasing the number
of mappable bases slightly increases the correlation be-
tween RPKUM and RPKM levels (ρ = 0.97 for 100 map-
pable bases and ρ = 0.99 for 500 mappable bases).
Figure 2A shows the distribution of transcriptome
mappability for protein coding genes and GENCODE v.
17 pseudogenes. As expected, pseudogenes are much
less mappable than protein-coding genes; the median
protein-coding gene mappability value is nearly 100% of
gene length, and the vast majority of genes are almost
completely mappable. In contrast, the median pseudo-
gene mappability value is around 80% of pseudogene
length. The distribution of pseudogene mappability is











showing the distribution of gene and pseudogene mappability as a
the median, and the black box is the interquartile range. (B) Pie charts
o right: Fraction of all aligned reads that map to pseudogenes; fraction
reads uniquely aligned to pseudogenes that are also mappable.
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(2169 out of 14942). Nonetheless, the majority of pseudo-
genes possess a significant fraction of mappable bases and
are thus accurately detectable using RPKUM expression
levels.
As expected, restricting the set of reads aligned to
pseudogenes to only those in mappable regions leads to
a dramatic reduction in the number of reads (Figure 2B).
On average, each sample contains nearly 10 million
reads mapped to pseudogenes, but our filtering process
leaves a set of just over 360,000 pseudogene reads per
sample. The surviving reads comprise a high-confidence
set that can be used to assess pseudogene transcription.
High-confidence breast cancer pseudogene transcripts
Using the GENCODE v. 17 pseudogene annotations, we
identified 2012 pseudogenes with evidence of transcription,
defined as genes with at least 50 mappable bases, 50 reads,















































Figure 3 Pseudogene occurrence in the TCGA breast cancer samples
Cumulative distribution function showing how many samples pseudogene
occur in fewer than 20 samples. Roughly 25% of the pseudogenes occur in
pseudogenes transcribed in breast cancer with the full psiDR v. 0 annotatio
the set of 287 pseudogenes compared to the full set (p < 0.002, χ2 test).majority of these pseudogenes occurred in only a small
number of samples (Figure 3A). However, a subset of the
pseudogene transcripts occurs in a large number of sam-
ples, including 94 pseudogenes that are transcribed in over
95% (n = 780) of the samples. To investigate the pseudo-
genes that are most likely to play a role in cancer biology,
we chose to focus the remainder of our analysis on pseudo-
genes that exhibited evidence of transcription in at least
10% (n = 80) of the samples; this set consists of 440
pseudogenes.
The GENCODE pseudogene decoration resource
(psiDR v. 0), assembled from a recent genome-wide
survey of pseudogenes using ENCODE data [3], pro-
vides useful information for an initial assessment of
the transcriptional potential of our pseudogene set.
Out of the set of 440 transcribed pseudogenes we
identified, 287 pseudogenes are annotated in psiDR
for a number of attributes, including pseudogene type,
parent gene, transcription evidence, open chromatin,500 600 700 800 900
f Samples
seudogene Frequency








and overlap with ENCODE functional genomics annotations. (A)
s occur in. Approximately 65% of the 2,012 transcribed pseudogenes
at least 80 samples. (B) Bar chart comparing the set of 287
n set. The asterisks indicate categories that are significantly enriched in
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tion factor binding, RNA polymerase II occupancy,
and evolutionary constraint [3]. Although the func-
tional genomics annotations come from the ENCODE
cell lines, not from breast cancer tissue, they nonethe-
less serve as a reasonable starting point for assessing
the transcriptional activity of the pseudogenes we
identified.
Examining the collection of psiDR annotations for
these 287 transcribed pseudogenes shows that they pos-
sess a number of properties that indicate transcriptional
activity (Figure 3B). Nearly half (n = 125) of the 287
pseudogenes were reported by psiDR to be transcribed.
The remainder (n = 162) represent potentially novel
pseudogene transcripts not annotated in psiDR. The
pseudogenes producing these unannotated transcripts
show strong evidence of transcriptional activity. Com-
pared to the full set of more than 11,000 pseudogenes
annotated by psiDR, the set of 287 is significantly
enriched for active chromatin, Pol II occupancy, and
transcription factor binding (p<0.002,χ2test). In addition,
20 of these pseudogenes display fewer substitutions
compared to chimp and mouse orthologs than expected
by chance. Interestingly, duplicated and unitary pseudo-
genes are also enriched within the set of 287. This may
be due in part to the fact that duplicated pseudogenes
are thought to be more likely to possess upstream regu-
latory elements similar to those of the parent genes.
Also, unitary pseudogenes are likely to be more map-
pable, and thus are easier to detect from short-read
RNA-seq data. In short, the diverse data types from the
ENCODE project provide strong support for the tran-
scriptional activity of the pseudogenes that we have de-
tected in breast cancer tissue.
It is worth noting that PTENP1 and KRASP1, the two
initial examples of pseudogene ceRNAs, are present
(though at low levels) in the breast cancer samples we
study here. Our method of computing RPKUM expres-
sion levels is thus capable of detecting these important
pseudogenes, but their expression levels fall below the
cutoff that we used to define our set of highly-expressed
pseudogene transcripts, and therefore they were not
considered for further analysis. The set of 748 breast-
cancer pseudogene transcripts provided by Han et al.
[22] does not contain PTENP1 or KRASP1, confirming
the low expression of these pseudogenes in breast
cancer.
Hierarchical clustering shows association with known
cancer subtypes
The four molecular subtypes of breast cancer possess a
number of distinguishing characteristics, including
estrogen/progesterone receptor status, response to
chemotherapy drugs, and gene expression profile[25]. A common method of studying the differences
among these subtypes is to use unsupervised cluster-
ing techniques to group samples together based on
their gene expression patterns. Unsupervised cluster-
ing using protein-coding genes results in four dis-
tinct clusters corresponding to the subtypes [25]. To
investigate the relationship between pseudogene transcrip-
tion and breast cancer disease state, we performed hier-
archical clustering using the high-confidence set of 440
pseudogenes. Unsupervised clustering based solely on
these pseudogene expression levels effectively separates
tumor and normal samples (Figure 4A). However, since
the normal samples are extracted from tumor adjacent
breast tissue that contains a different cell type composition
than the tumor itself, the ability to distinguish tumor from
normal is likely due in large part to tissue specificity rather
than tumor biology. Nonetheless, this result shows that
pseudogene expression varies considerably between the
cell types that make up the tumor and adjacent normal
samples.
We also removed the adjacent normal samples and
clustered solely on the tumor samples. As Figure 4B
shows, the unsupervised clustering algorithm success-
fully separates the basal samples from the other sub-
types. However, the pseudogene expression profiles for
the luminal and Her2 subtypes are not sufficiently distinct
to consistently separate samples from these subtypes.
Basal tumors grow more rapidly and have significantly dif-
ferent histology than the other subtypes [25], and this may
be why basal/luminal and basal/Her2 separation stands
out more clearly than the luminal/Her2 separation. The
fact that pseudogene expression alone can identify the
basal subtype shows that pseudogene expression has a
strong, non-random association with specific pathways
and cellular environments. This suggests that previous
findings, such as the pseudogene ATP8A2, which is more
highly expressed in luminal compared to basal samples
[4], are not isolated examples.Pseudogenes are differentially expressed among cancer
subtypes
To identify the pseudogenes with the most strong
subtype-specific expression profiles, we performed a
multi-class differential expression analysis using the
SAM tool [26]. This analysis yielded 309 pseudogenes
with significant subtype-specific expression (FDR < 1%;
Additional file 2). Several interesting pseudogenes are at
the top of this list. For example, the second pseudogene
on the list is ATP8A2-Ψ, a pseudogene that has been
found to be upregulated in luminal subtypes and shown
to induce tumor progression [4]. The expression profile
found here reflects this pattern, showing strong upregu-
lation in luminal samples compared to basal.
AB
Figure 4 Hierarchical clustering based on pseudogene
expression shows pseudogene association with breast cancer
subtypes. (A) Heatmap showing pseudogene expression profiles in
tumor and adjacent normal samples. High expression levels are
shown in light green, and low expression levels are shown in light
blue. Tumor samples are highlighted in red along the top of the
plot; adjacent normal samples are highlighted in green. (B) Heatmap
of pseudogene expression profiles in tumor samples. Samples
belonging to the basal subtype are highlighted in yellow along the
top of the plot.
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A pseudogene of CASP4, a member of the caspase family
known to initiate apoptosis under certain conditions [27],
is expressed at higher levels in basal samples and down-
regulated in luminal A samples (Figure 5A). Interestingly,
the expression of the CASP4 pseudogene is lower in
tumor samples than normal, which is the expression pro-
file expected for a ceRNA that promotes CASP4 expres-
sion. Additionally, the CASP4 pseudogene was found to
be transcribed in the ENCODE analysis [3]. Another inter-
esting property of this unprocessed pseudogene is that it
shows alternative splicing—there appear to be multiple
isoforms represented in the reads covering the pseudogene
locus. Intriguingly, our analysis of potential ceRNA inter-
actions also indicated that the CASP4 pseudogene is posi-
tively correlated (ρ = 0.3) with expression of its parent
gene and shares a miRNA target site for hsa-mir-203 (see
next section for detailed summary of ceRNA investigation).
The CYP2F1 pseudogene is expressed at quite high
levels compared to most pseudogenes in the dataset, and
the average expression level in the luminal B subtype is
nearly five times the average expression in the basal sub-
type. The pseudogene is a unitary pseudogene, with no
clear parent protein-coding gene. However, it possesses
strong sequence similarity with the cytochrome P450
family of genes. It was previously demonstrated that
CYP2F1 is expressed in colorectal cancer and that ex-
pression in primary tumors correlated with correspond-
ing metastatic tumors in lymph nodes [28]. Like the
CASP4 pseudogene, the CYP2F1 pseudogene shows evi-
dence for multiple isoforms.
A pseudogene of the MSL3 gene shows nearly twice
the expression level in basal compared to luminal A
(Figure 5C). The processed pseudogene was found to be
transcribed in the ENCODE analysis. The MSL3 protein
is thought to play a function in chromatin remodeling
and transcriptional regulation, and it has been reported
as part of a complex that is responsible for histone H4
lysine-16 acetylation [29]. Furthermore, expression of
this pseudogene is correlated with the expression of its
parent gene (ρ = 0.3), and it is predicted to share target
sites for six different miRNAs (see next section for de-
tailed summary of ceRNA investigation).
AB
C
Figure 5 (See legend on next page.)
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Figure 5 Read coverage, mappability, and tumor expression profile for (A) CASP4 pseudogene, (B) CYP2F1 pseudogene, and (C) MSL3
pseudogene. The light green bars in the top track of indicate regions that are mappable. Read coverage is shown by the height of the gray
regions. Average expression level for each cancer subtype is shown to the right; pink indicates high expression, and light blue indicates
low expression.
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reveals pseudogenes with ceRNA potential
A common hypothesis about ceRNA interactions is that
if transcript A sequesters miRNA C away from transcript
B, the expression levels of A and B will be positively cor-
related, while both A and B will be negatively correlated
with C. To assess the possibility that the transcribed
pseudogenes identified may function as ceRNAs for their
parent genes, we performed an analysis integrating
miRNA target prediction with pseudogene, gene, and
miRNA expression levels. The miRNA expression levels
(Additional file 3) were computed from sample-paired
TCGA small RNA-seq data using a previously described
small RNA-seq analysis pipeline [30]. We computed ex-
pression levels for the parent genes of the pseudogenes
using the same RPKUM method as for the pseudogenes.
Since pseudogenes are non-coding RNAs and are not
densely bound by ribosomes, the vast majority of the
transcribed region of a pseudogene is likely accessible
for miRNA binding. However, if a pseudogene serves as
a miRNA sponge for its parent gene, it is more likely
that the shared miRNA binding site occurs in the 3′
UTR of the parent gene than in the coding region. In
addition, using a restricted region for prediction some-
what ameliorates the lack of specificity common to
miRNA target prediction algorithms [31]. We therefore
chose to restrict our target prediction analysis to the
portion of the pseudogene with sequence similarity to
the 3′ UTR of the parent gene—what might be termed
the “pseudo-3′ UTR”. During the process of performing
miRNA target prediction on pseudogenes, we noticed
that the GENCODE pseudogene annotations often did
not span the pseudo-3′ UTR. Therefore, we used
BLAST to identify the pseudo-3′ UTRs of pseudogenes
by aligning the GENCODE annotation and surrounding
genomic context with the annotated 3′ UTRs of the par-
ent gene (see Methods section for details). TargetScan
version 7 [32] was used to predict target sites for only
the top 100 miRNAs expressed in the TCGA breast can-
cer dataset. This analysis revealed 177 transcribed pseu-
dogenes that are predicted to share at least one miRNA
target site with their corresponding parent genes.
We computed Pearson correlation coefficients for each
pseudogene-parent gene pair. As the plot in Figure 6
shows, the majority of pseudogene-parent gene pairs are
uncorrelated. However, there is a positive skew to the
distribution of correlations. To test whether the distribu-
tion of correlations differs significantly from expectation,we performed a permutation test. We constructed 5000
sets of gene-pseudogene pairs in which the genes and
pseudogenes were randomly paired. The sets were of the
same size as the set of pseudogene-parent gene pairs.
For each random set, we computed the number of pairs
with Pearson correlation above 0.3. In the 5000 random
sets we generated, there were never more than 15 such
pairs per set (Figure 6C). However, the set of correla-
tions resulting from pairing pseudogenes and parent
genes contains 55 pairs with correlation above 0.3. This
indicates that the positive skew to the distribution of
correlations shown in Figure 6A is very unlikely to be
due to chance. We also tested an additional correlation
threshold of 0.5 and observed a similar result, indicating
that our findings are robust to the choice of correlation
threshold.
We also computed the correlation between the expres-
sion level of each pseudogene and the miRNAs predicted
to target it. The correlations observed for these
pseudogene-miRNA pairs closely approximate a nor-
mal distribution, but show a slight negative trend
(Figure 6B). A total of 180 pseudogene-miRNA pairs
show strong negative correlation of less than −0.3.
To test whether this number of pairs is significant,
we approximated a null distribution of pseudogene-miRNA
correlations using the same permutation method we ap-
plied to the pseudogene-parent gene pairs. Randomly shuf-
fling the pseudogene-miRNA pairs to create 5000 random
sets (Figure 6D) showed only 5 permutations with at least
as many strongly anti-correlated pairs as we observed in
the data, which corresponds to an empirical p-value of
0.001. This supports the conclusion that the extent of nega-
tive correlations observed in the data cannot be attributed
solely to chance, and is likely due to genuine miRNA target
repression.
Next we sought to identify the pseudogene-parent
gene-miRNA triples with the strongest ceRNA potential.
To do this, we first identified expressed miRNAs pre-
dicted to target both a pseudogene and its parent gene.
For each such triple, we computed the correlation be-
tween pseudogene and parent gene, pseudogene and
miRNA, and parent gene and miRNA (Additional file 4).
We also computed p-values with Benjamini-Hochberg
FDR correction for the miRNA correlations. In this way,
we identified 17 pseudogene-gene pairs with strong
ceRNA potential, which we defined as pseudogene-gene
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Figure 6 Violin plots summarizing pseudogene-parent gene and pseudogene-miRNA pairwise correlations. Correlations between (A)
expressed pseudogenes and parent genes and (B) expressed pseudogenes and expressed miRNAs predicted to target them. Results of
permutation analysis showing how many correlated pseudogene-parent gene pairs (C) and pseudogene-miRNA pairs (D) were found.
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teresting examples. A pseudogene of GBP1 and its par-
ent gene show statistically significant anti-correlation
with hsa-mir-199a, which has been shown to regulate
autophagy in breast cancer cells [33]. This pseudogene
was also found to be transcribed in the ENCODE ana-
lysis [3]. The parent gene GBP1 is known to be the me-
diator of the anti-proliferative effect of inflammatory
cytokines in endothelial cells [34], and is implicated in
several types of cancer according to GeneCards. In
addition, the GBP1 pseudogene shows strong positive
correlation with the expression of its parent gene across
the TCGA dataset (ρ = 0.82). Another interesting pseudo-
gene is SUZ12P1. This pseudogene and its parent gene
both show strong anti-correlation to hsa-mir-28. SUZ12P1
also shows moderate positive correlation with its parent
gene (ρ = 0.41). The parent gene, SUZ12, is a polycomb
group protein and part of the PRC2/EED-EZH2 complex,
an important epigenetic regulator that performs histone
methylation [35]. This gene is also frequently translocated
in endometrial stromal tumors, where it forms the JAZF1-
SUZ12 oncogene [36].
An interesting question is whether the genes that have
pseudogenes with ceRNA potential are functionally re-
lated. To investigate this question, we performed a Gene
Ontology (GO) term enrichment analysis using threedifferent sets of parent genes. The sets of genes used
were parent genes strongly correlated with a pseudo-
gene, parent genes whose pseudogenes was strongly
anti-correlated with a shared miRNA, and parent genes
participating in a putative gene-pseudogene-miRNA
ceRNA interaction as defined above. For each of these
sets of parent genes, we used the GOrilla tool with de-
fault settings to look for GO terms enriched in the set
compared to the background list of all parent genes. No
significantly enriched GO terms were found for any of
the 3 sets of interest, indicating that there is no clear
functional relationship among the parent genes in the
sets that we have identified.
Discussion
The recent paper by Han et al. that investigated pseudo-
gene expression in cancer [22] identified 748 pseudo-
genes transcribed in breast cancer, 547 of which showed
subtype-specific expression. Although the results of Han
et al. partially overlap with our own, our study is distinct
in two key ways: (1) we investigate the ceRNA potential
of pseudogenes transcribed in breast cancer, but Han
et al. do not and (2) we use a more detailed method for
measuring pseudogene transcription, designed to maximize
specificity. In an effort to avoid the artifacts that plague
pseudogene transcription detection, we designed our
Welch et al. BMC Genomics  (2015) 16:113 Page12of16analysis to be as conservative as possible. Consequently, the
set of pseudogenes detected by our method is somewhat
smaller. However, our set of pseudogenes is not simply a
subset of theirs. Out of the 440 pseudogenes we detect, only
174 were also found by Han et al. (Figure 7B). The
remaining 266 represent novel pseudogene transcripts. In
addition, 103 of the subtype-specific pseudogenes we identi-
fied overlap with the set of subtype-specific pseudogenes
presented in Han et al. (Figure 7C).
To understand why our set of pseudogenes is substan-
tively different from that of Han et al., we carefully ana-
lyzed how they computed pseudogene expression levels.
They used 75-mers to compute mappability, and decided
for each exon whether to include or exclude reads for
the entire exon. One shortcoming of this approach is
that it either includes or excludes reads for entire exons,
rather than making decisions for individual reads. In our
experience, small islands of similarity within an other-
wise distinct exon are often enough to promote false
positive read alignments. Conversely, small islands of
distinct sequence within an exon can be used to detect
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Figure 7 Comparison with the results of Han et al. (A) Violin plots show
and accounting for splice junctions inserted in the genome (yellow) and 75-m
found by Han et al. (C) Comparison with breast cancer subtype-specific pseudapproach detected 266 pseudogenes with strong evidence
of transcription that were overlooked in Han et al. [22].
Another limitation is that the analysis in [22] did not ac-
count for the presence of splice junctions inserted into the
genome. Processed pseudogenes containing concatenated
exons are a major source of error in pseudogene RNA-seq
alignments because RNA-seq aligners sometimes prefer
unspliced alignments to spliced, particularly in the pres-
ence of SNPs. However, genomic mappability as used in
[22] cannot detect such artifacts.
A more serious problem is that although the RNA-seq
reads from the TCGA BRCA data are 50 bases long,
Han et al. use mappability based on 75-mers to decide
which pseudogenes are mappable. Given that longer se-
quences are more likely to be distinct in the genome,
this mismatch between read length and the k-mer size
used to compute mappability means that an exon that
appears completely mappable may nonetheless have
many misaligned reads. Figure 7A shows the difference
in mappability obtained from 75-mers without accounting
for splice junctions inserted in the genome and 50-
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ing the difference in pseudogene mappability when using 50-mers
ers (blue). (B) Comparison with breast cancer pseudogene transcripts
ogene transcripts found by Han et al.
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case it is 74%. The use of 75-mers as in [22] rather than
50-mers results in a loss of specificity. Thus, it is pos-
sible that some of the pseudogenes transcripts detected
in this way are not actually transcribed, but are simply
read alignment artifacts.
In summary, two major differences between the ap-
proach of Han et al. and our own method for computing
pseudogene expression explain the differing lists of pseu-
dogenes that were obtained. First, Han et al. either kept
or removed entire pseudogene exons, while we made the
decision for each individual read; this explains why we
detected some pseudogenes that they did not. Second,
Han et al. used 75-mers to compute genome mappabil-
ity, but we used 50-mers and accounted for processed
pseudogenes containing splice junctions; consequently,
our list of pseudogenes did not include some of theirs.
We emphasized specificity in our algorithm in order to
facilitate the identification of the highest confidence
pseudogenes and candidate ceRNAs for further analysis.
If the methods used to derive pseudogene expression
levels do not properly account for misaligned reads, it
is difficult to exclude the possibility that apparent
pseudogene-based classification of subtypes are actually
driven by improperly aligned reads from protein-coding
genes with subtype-specific expression. Furthermore, such
misaligned reads could bias toward stronger positive cor-
relations between parent genes and pseudogenes.
In this paper, we undertook an initial investigation to
address the important questions of how pervasive the
pseudogene ceRNA mechanism is and how pseudogene
transcription relates to breast cancer subtype. Careful
scrutiny of RNA-seq evidence yielded a high-confidence
set of pseudogene transcripts, a subset of which exhibit
strong subtype-specific expression and are candidates
for ceRNA function. Further experimental work is
needed to examine these candidates; in particular, assays
for miRNA binding and siRNA knockdown experiments
can provide more conclusive evidence for ceRNA inter-
actions in individual gene-pseudogene pairs. Follow-up
studies are also needed to determine the nature of the
relationship between pseudogene expression and subtype.
Many of the subtype-specific pseudogene transcripts are
likely passengers rather than drivers. However, some of
these may play a role in the tumor progression of individual
subtypes, as was demonstrated in the case of ATP8A2-Ψ.
The integration of pseudogene, gene, and miRNA ex-
pression data demonstrates that while not all pseudo-
genes may function as ceRNAs, the phenomenon is
likely more pervasive than currently appreciated. One
limitation of our approach is that ceRNA activity may
not always be indicated by positive correlation between
a pseudogene and its parent gene or negative correlation
between a pseudogene and its targeting miRNA. Forexample, if the miRNA regulation of a pseudogene
is very strong, leading to rapid and robust degradation
of the pseudogene, this could produce a negative
correlation between pseudogene and parent gene. Fur-
thermore, it is well-known that regulatory network
structures such as incoherent feed-forward loops can
produce positive correlation between an mRNA and a
targeting miRNA [37]. Even with this limitation, our
results suggest that more pseudogenes than currently
known likely function as ceRNAs, and more detailed
experimental work is required to determine the physio-
logical significance of this function.Methods
Computing transcriptome mappability
A first approach to reliably studying pseudogene expres-
sion is to consider only reads that are assigned to a sin-
gle location by an aligner. However, the confounding
factors of SNPs, read errors and aligner heuristics can
result in reads that are uniquely aligned to the wrong
positions (Figure 1A). We refer to such reads as uniquely
misaligned reads. Any conclusions drawn in the pres-
ence of uniquely misaligned reads in downstream ana-
lyses will be unreliable. In order to guard against this
problem, we should distrust any reads for which there
exist multiple possible alignments whose distance from
the genome is less than some safety margin ε (Figure 1B).
In such cases, there is sufficient ambiguity that we can-
not rule out the possibility of unique misalignment.
To address the problem of read mismapping between
genes and pseudogenes, we developed an approach
based on the concept of mappability. Since RNA-seq
reads may span multiple exons, the transcriptome con-
tains additional k -mers beyond those found in the gen-
ome. In considering transcriptome k -mers, two cases
arise that are particularly problematic for pseudogenes:
processed pseudogenes with integrated splice junctions
and duplicated pseudogenes that may have highly similar
splice junctions to their parent genes. The former case is
particularly problematic because RNA-seq aligners
sometimes prefer direct alignments to spliced align-
ments, causing spuriously aligned reads to accumulate
on processed pseudogenes. To compute transcriptome
mappability, we consider k -mers from the genome and
“synthetic regions” surrounding splice junctions (Figure 1D).
The synthetic region around a splice junction is the concat-
enation of the immediately adjacent k–1 bases from donor
and acceptor exons. These regions thus contain any k
-mers that span annotated splice junctions. For a
given genome G, transcriptome T (represented as k
-mers from synthetic regions), position i, read length k
and error tolerance ε, we define the mappability of
position i as a Boolean quantity:
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0 if Gi …Giþk−1 is within Hamming distance





We filtered reads by requiring that either (1) the read
has a unique, direct alignment to the genome starting at
position i and this position is mappable or (2) the read
has a unique, spliced alignment and the spliced k -mer
to which the read is aligned occurs exactly once in the
genome and transcriptome. We refer to reads surviving
this filtering as “mappable reads”. Ensembl protein-
coding gene annotations and GENCODE pseudogene v.
14 annotations were used to compute synthetic regions
around splice junctions.
The number of mappable bases for each pseudogene
was computed by constructing a “consensus pseudogene
model” in which all annotated exons are merged into a
nonredundant set of positions including all potentially
transcribed regions from the gene model. We count a
position within the resulting nonredundant set of tran-
script positions as mappable if either (1) the correspond-
ing position in the genome is mappable or (2) a
mappable spliced read occurs at that position.
Using the reliably mapped reads and mappable bases,
compute pseudogene expression levels in units of Reads
per Kilobase of Uniquely mappable transcript per Mil-
lion reads (RPKUM):
Expression level in RPKUM
¼ Mappable reads from pseudogene  10
9
Mappable bases in pseudogene  total reads
The justification for computing expression levels in
units of RPKUM instead of RPKM is that reads aligned
to unmappable regions are not considered in the expres-
sion level calculation, so counting the total number of
bases in the transcript would underestimate the expres-
sion level. One limitation of the RPKUM metric is when
the regions used to determine pseudogene transcription
are disjoint from a transcript isoform. In such a case the
RPKUM expression measurement does not include the
expression of the unmappable isoform. Out of 14,943
pseudogenes annotated by GENCODE v.17, only 89
pseudogenes have one or more unmappable transcript
isoform (defined as < 50 mappable bases). Only 17 of
these occur in the set of 440 that we analyze in the
paper, and of this set of 17, only 5 have parent genes.
Figure 1C summarizes our pipeline for computing
pseudogene expression levels. Our approach improves
on the strategy used in [3] and [4]. In [38] a method was
proposed that, as ours, tries to avoid uniquely misaligned
reads and also included a measure of mappability.However, the method developed in [38] applied only to
processed pseudogenes and could not be used for dupli-
cated pseudogenes. Our method also accounts for the
possibility of reads that cross splice alignments in defin-
ing mappability.
Hierarchical clustering and differential expression analysis
Tumor subtype classification was determined using the
PAM50 score [39]. Unsupervised hierarchical clustering
was performed using the R function hclust. Expression
levels were log transformed and normalized using the R
scale function before clustering. We first performed
clustering using both tumor and adjacent normal sam-
ples. Next, we omitted the adjacent normal samples and
clustered only the tumor samples. To determine which
pseudogenes showed significant subtype-specific expres-
sion, we used the Significance Analysis of Microarrays R
package (samr) [26]. This approach uses a nonparamet-
ric test based on the Kruskal-Wallis statistic to assess
the evidence for rejecting the null hypothesis that the
expression levels do not differ among subtypes. The
multiclass differential expression option of the samr
package was used.
Prediction of miRNAs targeting pseudogenes and genes
Since pseudogenes are thought to be non-coding and
thus not densely bound by ribosomes, the entire tran-
script can be targeted by miRNAs. Also, since pseudo-
genes are non-coding, 3′ UTRs are not annotated for
pseudogenes. However, if a miRNA targets both a
pseudogene and its parent gene, the shared miRNA
binding site is likely to be located in the 3’ UTR of the
parent gene and the corresponding “pseudo-3′ UTR” of
the pseudogene. In order to be more conservative and in
an effort to reduce the number of false positives arising
from the lack of specificity in miRNA target prediction
algorithms, we chose to restrict our analysis to the
pseudo-3′ UTRs of pseudogenes; we therefore had to
annotate these regions. Pseudo-3′ UTRs were annotated
by BLAST alignment to the 3′ UTRs of the parent
genes.
For each parent gene-pseudogene pair, we downloaded
all annotated 3′ UTRs for the parent gene. Next, we ex-
tracted the pseudogene locus according to GENCODE
and 10 kb of genomic context on either side of the
pseudogene. BLAST was then used to align the parent
gene 3′ UTRs against the pseudogene plus genomic con-
text. The longest statistically significant alignment (based
on the BLAST E-value) was taken to be the pseudo-3′
UTR. Target prediction was performed on pseudo-3′
UTRs and annotated gene 3′ UTRs using TargetScan ver-
sion 7 [32]. Only miRNA target seeds from the top 100
expressed miRNAs by average expression level across the
samples were used in the target prediction. Isomirs
Welch et al. BMC Genomics  (2015) 16:113 Page15of16(mature miRNAs resulting from a shift in the annotated
transcription start site of the same miRNA locus) were
considered to be different miRNAs in this analysis. A
miRNA was considered to be “shared” between a pseudo-
gene and parent gene if TargetScan predicted that the
miRNA could target both of them.Correlation with protein-coding gene and miRNA expression
levels
We computed Pearson correlation coefficients on log-
transformed gene and pseudogene expression levels
using the parent gene annotations from the ENCODE
pseudogene decoration resource (psiDR v. 0). To avoid
detecting spurious correlations due to predominantly
low expression, we required at least 20 samples in which
gene and pseudogene are present at 1 RPKUM or
greater. Gene-pseudogene pairs with fewer than 20 such
samples were omitted from the analysis. We used the
miRNA targeting predictions from TargetScan (see “Pre-
diction of miRNAs targeting pseudogenes and genes”) to
compute correlations between pseudogene and miRNA
expression levels. Only the top 100 miRNAs by average
expression level were used for this analysis. The pipeline
described in Baran-Gale et al. [30] was used to compute
miRNA expression levels from the TCGA small RNA-
seq data. Correlations with miRNAs were assessed by
computing p-values using a T-statistic for the null hy-
pothesis that the correlation is no smaller than 0. False
discovery rate correction using the method of Benjamini
and Hochberg was performed with the R function p.
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